NCT02541760View on ClinicalTrials.gov

Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Otitis Media With Effiusion
Interventions
DRUG

Monteleukast

4 ml monteleukast daily for one month

DRUG

Mometasone

Inhaled mometasone 1 puff in each side of nose for one month

Trial Locations (1)

097145-3388

Hormozgan University of Medical Sciences, Bandar Abbas

All Listed Sponsors
lead

Hormozgan University of Medical Sciences

OTHER

NCT02541760 - Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children | Biotech Hunter | Biotech Hunter